| Structure | Chemical Name | CAS | MF |
|
ethyl 5-amino-1-(3-fluorophenyl)-1H-pyrazole-4-carboxylate
|
138907-70-7
|
C12H12FN3O2
|
|
5-AMINO-1-(4-BROMO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
|
138907-71-8
|
C12H12BrN3O2
|
|
5-AMINO-1-(2,4-DIFLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
|
138907-72-9
|
C12H11F2N3O2
|
|
ethyl 1-(4-fluorophenyl)-1H-pyrazole-4-carboxylate
|
138907-73-0
|
C12H11FN2O2
|
|
1H-Pyrazole-4-carboxylic acid
|
138907-76-3
|
C12H11BrN2O2
|
|
1-(4-Methoxyphenyl)-1H-pyrazole-4-carboxylic acid
|
138907-79-6
|
C11H10N2O3
|
|
1-(4-chlorophenyl)-1H-pyrazole-4-carboxylic acid
|
138907-80-9
|
C10H7ClN2O2
|
|
1-(4-FLUORO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID
|
138907-81-0
|
C10H7FN2O2
|
|
1-(3-fluorophenyl)-1H-pyrazole-4-carboxylic acid
|
138907-82-1
|
C10H7FN2O2
|
|
1-(4-bromophenyl)-1H-pyrazole-4-carboxylic acid
|
138907-85-4
|
C10H7BrN2O2
|
|
CL 316243
|
138908-40-4
|
C20H18ClNO7.2Na
|
|
4-Pentylbenzamide
|
138913-07-2
|
C12H17NO
|
|
3-Oxa-1,5-diazabicyclo[3.3.1]nonane(9CI)
|
138913-25-4
|
C6H12N2O
|
|
1H-1,3-Diazepine,hexahydro-1,3-dimethyl-(9CI)
|
138913-26-5
|
C7H16N2
|
|
1H-1,3-Diazepine-1-carboxaldehyde, hexahydro-3-methyl- (9CI)
|
138913-28-7
|
C7H14N2O
|
|
ochraceolide A
|
138913-61-8
|
C30H44O3
|
|
ochraceolide B
|
138913-62-9
|
C30H44O4
|
|
ochraceolide C
|
138913-63-0
|
C30H42O4
|
|
3-NITROPENTANENITRONATE
|
138914-13-3
|
C5H10NO2-
|
|
2-(bromoethanoyloxy)-2-phenylethanoic acid
|
138914-16-6
|
C10H9BrO4
|
|
H-Pro-Arg-βNA · HCl
|
138914-35-9
|
C21H28N6O2
|
|
JM 34
|
138914-64-4
|
C12H12N2O2
|
|
2-Pyrimidinamine, 5-ethyl-4,6-dimethoxy- (9CI)
|
138915-47-6
|
C8H13N3O2
|
|
Dansyllysyl(8)-vasotocin
|
138915-83-0
|
C55H78N14O14S3
|
|
(E)-N-[2-(β-D-Glucopyranosyloxy)ethyl]-3-methylthiopropenamide
|
138916-58-2
|
C12H21NO7S
|
|
8-Azabicyclo[3.2.1]oct-2-ene-2-carboxaldehyde, 8-methyl- (9CI)
|
138921-06-9
|
C9H13NO
|
|
Phenyl 4,6-O-benzylidene-bD-thiogalactopyranoside
|
138922-03-9
|
C19H20O5S
|
|
Methyl (1S,4R)-4-Amino-2-Cyclopentene-1-Carboxylate
|
138923-03-2
|
C7H11NO2
|
|
Ibandronate sodium monohydrate
|
138926-19-9
|
C9H24NNaO8P2
|
|
1,4-Cyclohexanedicarboxylic acid, polymer with 2,2-dimethyl-1,3-propanediol, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol and 4,4-(1-methylethylidene)biscyclohexanol
|
138926-23-5
|
C34H66O11
|
|
protein 15K, Chlamydia trachomatis
|
138930-06-0
|
|
|
|
protein 60K, Chlamydia trachomatis
|
138930-07-1
|
|
|
|
CAP102
|
138930-21-9
|
|
|
|
HIV-enhancer binding protein EP2
|
138930-35-5
|
|
|
|
CAL1 protein
|
138930-37-7
|
|
|
|
P-protein, bacterial
|
138930-44-6
|
|
|
|
AWD 56-02
|
138931-78-9
|
|
|
|
hemoglobin Dhonburi
|
138932-11-3
|
|
|
1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone
|
138932-35-1
|
|
|
Benzoic acid, 4-(1-hydroxyethyl)-, 2-methylbutyl ester, [S-(R*,R*)]- (9CI)
|
138935-09-8
|
C14H20O3
|
|
5,5'-di-O-(diferul-9,9'-dioyl)arabinofuranosyl-(1-3)-xylopyranosyl-(1-4)-xylopyranose
|
138935-21-4
|
C50H66O32
|
|
dichlorolissoclimide
|
138935-82-7
|
C20H29Cl2NO4
|
|
5,6-DIHYDROXYINDOLINE HBr
|
138937-28-7
|
C8H10BrNO2
|
|
Pyrido[1,2-a]benzimidazol-4-ol (9CI)
|
138942-47-9
|
C11H8N2O
|
|
3-AMINO-1-PHENYL-1H-PYRAZOLE-4-CARBONITRILE
|
138942-61-7
|
C10H8N4
|
|
N-(Benzyloxycarbonyl)-D-norleucine methyl ester
|
138942-76-4
|
C15H21NO4
|
|
1,3-Dioxane-5-carboxylicacid,2-methyl-,cis-(9CI)
|
138943-96-1
|
C6H10O4
|
|
1,3-Dioxane-5-carboxylicacid,2-methyl-,trans-(9CI)
|
138943-97-2
|
C6H10O4
|
|
5-[2-(2-PHENYL)ETHYL]PHENYL-1H-TETRAZOLE, 97
|
138944-20-4
|
C15H14N4
|
|
2-METHOXY-5-METHYL-4-PHENYLCARBAMOYLIMIDAZOLE
|
138944-33-9
|
C12H13N3O2
|
|
2,3-Pyridinedicarboxylic Acid-d3
|
138946-42-6
|
C7H5NO4
|
|
Benzenemethanol, -alpha--methyl-4-(2-methylpropyl)-, acetate (9CI)
|
138948-58-0
|
C14H20O2
|
|
Benzoic acid, 4-[2-(1-oxobutoxy)propyl]-, (+)- (9CI)
|
138948-88-6
|
C14H18O4
|
|
1-[3-CHLORO-5-(TRIFLUOROMETHYL)PYRID-2-YL]-1-METHYLHYDRAZINE
|
138949-13-0
|
C7H7ClF3N3
|
|
1H-Purin-2-amine, 8-methyl- (9CI)
|
138949-63-0
|
C6H7N5
|
|
1H-Purin-8-amine, 6-methyl- (9CI)
|
138949-65-2
|
C6H7N5
|
|
THR-ARG-SER-ALA-TRP
|
138949-73-2
|
C27H41N9O8
|
|
4-Pregnen-17a, 20b-diol-3-one-20-sulfate
|
138949-80-1
|
C21H32O6S
|
|
NAZUMAMIDE A
|
138949-86-7
|
C28H43N7O8
|
|
3,4-secotrachylobanoic acid
|
138950-24-0
|
C20H30O2
|
|
2-METHOXY-5-FLUOROURACIL
|
138954-92-4
|
C5H6FN2O3
|
|
|
SatuMoMab Pendetide
|
138955-26-7
|
|
|
1,6,7,10-TETRAMETHYLFLUORANTHENE
|
138955-77-8
|
C20H18
|
|
N-Acetoxy Cyclosporin A Acetate
|
138957-23-0
|
C66H115N11O15
|
|
D-Proline, 5-ethynyl-, (5S)-rel- (9CI)
|
138957-97-8
|
C7H9NO2
|
|
D-Proline, 5-ethynyl-, (5R)-rel- (9CI)
|
138957-98-9
|
C7H9NO2
|
|
L-Proline, 4-(fluoromethylene)-, (E)- (9CI)
|
138958-01-7
|
C6H8FNO2
|
|
L-Proline, 4-(fluoromethylene)-, (Z)- (9CI)
|
138958-02-8
|
C6H8FNO2
|
|
2-Propenoic acid, 3-phenyl-, 2,2-diMethylpropyl ester, (E)-
|
138964-29-1
|
C14H18O2
|
|
2-Propenoic acid, 3-phenyl-, 1-ethylpropyl ester, (2E)-
|
138964-36-0
|
C14H18O2
|
|
6-Bromo-1H-quinoline-2,4-dione
|
138964-51-9
|
C9H6BrNO2
|
|
2,4(1H,3H)-QUINOLINEDIONE, 6-CHLORO
|
138964-52-0
|
C9H6ClNO2
|
|
Isocoronarin D
|
138965-88-5
|
C20H30O3
|
|
Coronarin D ethyl ether
|
138965-89-6
|
C22H34O3
|
|
N-(5,5-diacetoxypentyl)doxorubicin
|
138967-27-8
|
C36H43NO15
|
|
Benzoic acid, 4-[1-methyl-2-(1-oxobutoxy)ethyl]-, (+)- (9CI)
|
138967-28-9
|
C14H18O4
|
|
benastatin A
|
138968-85-1
|
C30H28O7
|
|
benastatin B
|
138968-86-2
|
C30H30O7
|
|
2,3-Dihydro-1H-indol-2-ylmethanol
|
138969-57-0
|
C9H11NO
|
|
1-Piperazinecarboxaldehyde, 4-(chloroacetyl)- (9CI)
|
138969-82-1
|
C7H11ClN2O2
|
|
11-(1-Methyl-4-piperidylidene)-6,11-dihydrodibenzo(b,e)thiepine-9-carb oxylic acid HCl
|
138970-91-9
|
|
|
BOC-D-DIPHENYLALANINE-L-PROLINE
|
138971-65-0
|
C25H30N2O5
|
|
1H-Benzimidazole,2-ethenyl-,3-oxide(9CI)
|
138972-85-7
|
C9H8N2O
|
|
1H-Benzimidazole,2-ethenyl-1-methoxy-(9CI)
|
138972-86-8
|
C10H10N2O
|
|
CAPSAZEPINE
|
138977-28-3
|
C19H21ClN2O2S
|
|
Cyclohexanecarboxaldehyde, 4-ethoxy-, trans- (9CI)
|
138981-02-9
|
C9H16O2
|
|
Ziprasidone hydrochloride monohydrate
|
138982-67-9
|
C21H24Cl2N4O2S
|
|
T-BUTYL(DICHLOROMETHYL)DIMETHYLSILANE
|
138983-08-1
|
C7H16Cl2Si
|
|
5-TRIMETHYLSILYLTHIOPHENE-2-BORONIC ACID
|
138983-68-3
|
C7H13BO2SSi
|
|
DIRHODIUM (II) TETRAKIS(CAPROLACTAM)
|
138984-26-6
|
C24H44N4O4Rh2
|
|
|
D-Glucopyranoside, methyl, isooctadecanoate (2:3)
|
138985-20-3
|
|
|
|
major T cell antigen, Mycobacterium leprae
|
138988-32-6
|
|
|
|
POLYPHENON 60
|
138988-88-2
|
|
|
pedicularioside H
|
138989-16-9
|
C36H48O19
|
|
2'-deoxythymidine-5'-(alpha-methylphosphonyl)-beta,gamma-diphosphate
|
138989-23-8
|
C11H19N2O13P3
|
|
3,4-Dihydro-1,3,4-triphenylpyridin-2(1H)-one
|
138991-02-3
|
|
|
(2-BUTYL-BENZOIMIDAZOL-1-YL)-ACETIC ACID
|
138992-92-4
|
C13H16N2O2
|
|
Calciumvalproat-dihydrat
|
138995-18-3
|
C8H20CaO3
|
|
Levofloxacin Impurity 18
|
138998-47-7
|
C14H13F4NO3
|
|
Cyclopentanecarboxylic acid, 1-[(2-amino-1-oxopropyl)amino]-, (S)- (9CI)
|
138999-55-0
|
C9H16N2O3
|